Ucb, INC.

Biopharmaceutical company

Based in GA

🤖

AI Overview

With $1.6M in lobbying spend across 26 quarterly filings, Ucb, INC. is a significant lobbying presence.

$1.6M
Total Lobbying Spend
26
Quarterly Filings
1
Lobbying Firms Used
7
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$128K
2019$180K
2020$180K
2021$240K
2022$240K
2023$240K
2024$180K
2025$180K

Lobbying Firms

THE NICKLES GROUP, LLC

What They Lobby For

  • Issues related to Epilepsy Centers of Excellence.
  • Issues related to value based purchasing; issues related to reimbursement of Part B and D drugs; issues related to drug pricing.
  • H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680 Opioid Crisis Response Act of 2018 and issues related to prescription drug monitoring; issues related to clinical trials; monitored issus related to prescription drug pricing.
  • Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act.
  • H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680 Opioid Crisis Response Act of 2018 and issues related to prescription drug monitoring.
  • Issues related to the reimbursement of Part B and D drugs; issues related to drug pricing.
  • Issues related to S. 1895, Lower Health Care Costs Act of 2019; issues related to the STAR Act.
  • Monitor issues on S. 1416, Affordable Prescriptions for Patients Act of 2019.
  • Issues related to the reimbursement of Part B and D drugs; issues related to drug pricing; issues related to the six protected classes; issues related to the safe harbor protection.
  • Issues related to S. 1895, Lower Health Care Costs Act of 2019; issues related to H.R. 2296, The METRIC Act; issues related to fall prevention.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.